AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23410714 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system (LNG-IUS)
Number of subjects: 24
Study 21837695 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol with calcium carbonate
Number of subjects: 306
Study 21837695 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol with calcium carbonate
Number of subjects: 306
Study 21837695 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine supplementation (calcitriol or cholecalciferol)
Number of subjects: 306
Study 21837695 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand supplementation (calcitriol or cholecalciferol)
Number of subjects: 306
Study 19064985 — intervention group
Group type: COMPARATOR
Intervention: Resistance exercise
Number of subjects: 121
Study 19064985 — intervention group
Group type: COMPARATOR
Intervention: Aerobic exercise
Number of subjects: 121
Study 19064985 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 121
Study 16648503 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan 65 mg/m2 IV + cisplatin 30 mg/m2 IV on days 1 and 8 every 21 days
Number of subjects: 331
Study 16648503 — intervention group
Group type: COMPARATOR
Intervention: Etoposide 120 mg/m2 IV on days 1 to 3 + cisplatin 60 mg/m2 IV on day 1 every 21 days
Number of subjects: 331
Study 16648503 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan/cisplatin
Number of subjects: 331
Study 16648503 — intervention group
Group type: COMPARATOR
Intervention: Etoposide/cisplatin
Number of subjects: 331
Study 14759591 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-influenza vaccination
Number of subjects: 20
Study 11706961 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticobasal degeneration
Number of subjects: 41
Study 11706961 — intervention group
Group type: EXPERIMENTAL
Intervention: Steele-Richardson-Olszewski syndrome (SRO)
Number of subjects: 41
Study 11706961 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple system atrophy (MSA)
Number of subjects: 41
Study 11706961 — intervention group
Group type: EXPERIMENTAL
Intervention: Idiopathic Parkinson's disease
Number of subjects: 41
Study 11706961 — intervention group
Group type: COMPARATOR
Intervention: Matched normals
Number of subjects: 41
Study 8809212 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerine administered sublingually
Number of subjects: 14
Study 1534248 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with high doses (1000 mg daily) of oral medroxyprogesterone acetate (HD-MPA)
Number of subjects: 142
Study 1534248 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 142
Study 1534248 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with HD-MPA
Number of subjects: 142
Study 2408425 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% topical minoxidil
Number of subjects: 23
Study 2408425 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 30049656 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time visual CPR feedback device
Number of subjects: 0
Study 30049656 — intervention group
Group type: COMPARATOR
Intervention: No feedback (control group)
Number of subjects: 0
Study 30049656 — intervention group
Group type: EXPERIMENTAL
Intervention: High workload (average score >60)
Number of subjects: 0
Study 30049656 — intervention group
Group type: EXPERIMENTAL
Intervention: Low workload (average score <60)
Number of subjects: 0
Study 27379625 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flux hemodialysis (HFHD)
Number of subjects: 51
Study 27379625 — intervention group
Group type: COMPARATOR
Intervention: Hemodialysis filtration (HDF)
Number of subjects: 51
Study 24685956 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-month physical activity intervention (70 minutes, 5 days/week)
Number of subjects: 220
Study 24685956 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 220
Study 21631592 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant-supported overdentures (IOD)
Number of subjects: 80
Study 21631592 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant-supported fixed dental prostheses (IFDP)
Number of subjects: 80
Study 21631592 — intervention group
Group type: COMPARATOR
Intervention: Conventional dentures (C/C)
Number of subjects: 80
Study 21631592 — intervention group
Group type: COMPARATOR
Intervention: Fully dentate controls (D/D)
Number of subjects: 80
Study 21631592 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant-supported prostheses (C/IOD and IFDP/IFDP)
Number of subjects: 80
Study 18413339 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration exercise (5 min, static squat, frequency 30 Hz)
Number of subjects: 20
Study 18413339 — intervention group
Group type: COMPARATOR
Intervention: Control (no vibration)
Number of subjects: 20
Study 17659490 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT) plus medication
Number of subjects: 124
Study 17659490 — intervention group
Group type: COMPARATOR
Intervention: Medication plus Clinical Management
Number of subjects: 124
Study 15966783 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based teaching program
Number of subjects: 381
Study 15966783 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based teaching program (subgroup analysis)
Number of subjects: 381
Study 12393819 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-conserving surgery (quadrantectomy) followed by radiotherapy
Number of subjects: 701
Study 12393819 — intervention group
Group type: COMPARATOR
Intervention: Radical mastectomy
Number of subjects: 701
Study 12393819 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-conserving surgery
Number of subjects: 701
Study 10330310 — intervention group
Group type: EXPERIMENTAL
Intervention: In-home educational visit by Milwaukee Health Department paraprofessional (n=187)
Number of subjects: 413
Study 10330310 — intervention group
Group type: COMPARATOR
Intervention: Reference group (n=226)
Number of subjects: 413
Study 10330310 — intervention group
Group type: EXPERIMENTAL
Intervention: In-home educational visit (n=187)
Number of subjects: 413
Study 8584384 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP-US
Number of subjects: 189
Study 8584384 — intervention group
Group type: COMPARATOR
Intervention: DTaP-J
Number of subjects: 189
Study 8584384 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP-US (i.m.)
Number of subjects: 189
Study 8584384 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP-US (s.c.)
Number of subjects: 189
Study 7682927 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine (25 or 50 mg)
Number of subjects: 11
Study 7682927 — intervention group
Group type: COMPARATOR
Intervention: Non-active placebo
Number of subjects: 11
Study 3551051 — intervention group
Group type: EXPERIMENTAL
Intervention: Pankreon granules 20 g per day
Number of subjects: 10
Study 3551051 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30174101 — intervention group
Group type: EXPERIMENTAL
Intervention: IANB with intraligamentary injection
Number of subjects: 96
Study 30174101 — intervention group
Group type: EXPERIMENTAL
Intervention: IANB with buccal injection
Number of subjects: 96
Study 30174101 — intervention group
Group type: COMPARATOR
Intervention: IANB alone
Number of subjects: 96
Study 28590322 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG
Number of subjects: 157
Study 28590322 — intervention group
Group type: COMPARATOR
Intervention: On-pump CABG
Number of subjects: 157
Study 28590322 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterial grafts
Number of subjects: 157
Study 28590322 — intervention group
Group type: EXPERIMENTAL
Intervention: Vein grafts
Number of subjects: 157
Study 28590322 — intervention group
Group type: EXPERIMENTAL
Intervention: Target territories
Number of subjects: 157
Study 23636182 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone cement loaded with erythromycin and colistin (study group)
Number of subjects: 2948
Study 23636182 — intervention group
Group type: COMPARATOR
Intervention: Bone cement without antibiotic (control group)
Number of subjects: 2948
Study 21838912 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric Monitoring Unit (GMU)
Number of subjects: 0
Study 21838912 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 19289931 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy or chemotherapy and radiotherapy combination
Number of subjects: 80
Study 19289931 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 80
Study 19289931 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall immune recovery
Number of subjects: 80
Study 19289931 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-gamma, IL-2, IL-4, lymphocyte proliferation, and natural killer cell activity
Number of subjects: 80
Study 17452584 — intervention group
Group type: EXPERIMENTAL
Intervention: Natalizumab
Number of subjects: 942
Study 17452584 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 942
Study 15090880 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis within 3 hours
Number of subjects: 0
Study 15090880 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial thrombolysis within 3-6 hours
Number of subjects: 0
Study 15090880 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis beyond 3 hours with improved selection criteria
Number of subjects: 0
Study 15090880 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis in general
Number of subjects: 0
Study 11495257 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin in fixed-dose combination (FDC) anti-tuberculosis formulations
Number of subjects: 0
Study 11495257 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary excretion data
Number of subjects: 0
Study 9265935 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental at 10 micrograms/ml
Number of subjects: 12
Study 9265935 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (1.4 micrograms/kg)
Number of subjects: 12
Study 9265935 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental at 5 and 7.5 micrograms/ml
Number of subjects: 12
Study 9265935 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 12
Study 8102107 — intervention group
Group type: EXPERIMENTAL
Intervention: Home elemental enteral hyperalimentation (HEEH)
Number of subjects: 84
Study 8102107 — intervention group
Group type: EXPERIMENTAL
Intervention: HEEH and drugs
Number of subjects: 84
Study 8102107 — intervention group
Group type: COMPARATOR
Intervention: Drugs
Number of subjects: 84
Study 8102107 — intervention group
Group type: COMPARATOR
Intervention: No maintenance therapy
Number of subjects: 84
Study 8102107 — intervention group
Group type: EXPERIMENTAL
Intervention: Elemental diet (ED) therapy (more than 30 kcal/kg ideal body weight/day)
Number of subjects: 84
Study 3524428 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin (1 g every 8 h)
Number of subjects: 337
Study 3524428 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole (2 g every 6 h)
Number of subjects: 337
Study 3524428 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime (1.5 g every 12 h)
Number of subjects: 337
Study 3524428 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 337
Study 3524428 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 337
Study 3524428 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 337
Study 3524428 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 337
Study 30256215 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebral blood flow velocity (CBFV) measured via transcranial Doppler
Number of subjects: 45
Study 30256215 — intervention group
Group type: EXPERIMENTAL
Intervention: End-tidal CO2 (EtCO2) measured via capnography
Number of subjects: 45
Study 30256215 — intervention group
Group type: EXPERIMENTAL
Intervention: RAP (rate of change of arterial pressure)
Number of subjects: 45
Study 30256215 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (BP)
Number of subjects: 45
Study 30256215 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic parameters (y min, y max, k, x) across haemodynamic variables
Number of subjects: 45
Study 30256215 — intervention group
Group type: EXPERIMENTAL
Intervention: CrCPmin and CrCPmax
Number of subjects: 45
Study 30256215 — intervention group
Group type: EXPERIMENTAL
Intervention: RAPmin and RAPmax
Number of subjects: 45
Study 27657520 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol MDPI 90 μg
Number of subjects: 61
Study 27657520 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol MDPI 180 μg
Number of subjects: 61
Study 27657520 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol HFA 180 μg
Number of subjects: 61
Study 27657520 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol HFA 90 μg
Number of subjects: 61
Study 27657520 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 24692735 — intervention group
Group type: EXPERIMENTAL
Intervention: bicalutamide
Number of subjects: 124
Study 24692735 — intervention group
Group type: EXPERIMENTAL
Intervention: chlormadinone
Number of subjects: 124
Study 22410389 — intervention group
Group type: EXPERIMENTAL
Intervention: MOVI-2 program (recreational physical activity in after-school time, including two 90-min sessions on weekdays and one 150-min session on Saturdays for one academic year)
Number of subjects: 1200
Study 22410389 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual patterns of physical activity)
Number of subjects: 1200
Study 22410389 — intervention group
Group type: EXPERIMENTAL
Intervention: MOVI-2 program
Number of subjects: 1200
Study 22410389 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1200
Study 20307903 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase (tPA)
Number of subjects: 0
Study 20307903 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 0
Study 20307903 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 0
Study 19260368 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous postoperative analgesia via epidural catheter
Number of subjects: 41
Study 19260368 — intervention group
Group type: COMPARATOR
Intervention: Oral and rectal non-steroidal pain-killers
Number of subjects: 41
Study 15915011 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 12 microg inhaled via HFA-134a inhaler (Modulite HFA)
Number of subjects: 38
Study 15915011 — intervention group
Group type: EXPERIMENTAL
Intervention: CFC pMDI containing formoterol
Number of subjects: 38
Study 15915011 — intervention group
Group type: EXPERIMENTAL
Intervention: DPI containing formoterol
Number of subjects: 38
Study 15915011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 12891190 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary angioplasty (for half of the 1100 patients transferred from referral hospitals)
Number of subjects: 1900
Study 12891190 — intervention group
Group type: COMPARATOR
Intervention: Fibrinolytic therapy (administered immediately at local hospitals)
Number of subjects: 1900
Study 10574676 — intervention group
Group type: EXPERIMENTAL
Intervention: Preresectional chemotherapy with mitomycin 6 mg/m2, ifosfamide 3 g/m2, and cisplatin 50 mg/m2, given intravenously on day 1 of each cycle at 3-week intervals followed by surgery.
Number of subjects: 60
Study 10574676 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone.
Number of subjects: 60
Study 8686824 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 2 micrograms.kg‐1 intravenously over 10 min after induction of anaesthesia
Number of subjects: 280
Study 1761240 — intervention group
Group type: EXPERIMENTAL
Intervention: Gynatren (lactobacillus vaccine)
Number of subjects: 167
Study 1761240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study 6282542 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram 250 mg at bedtime
Number of subjects: 30
Study 6282542 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 30537475 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate-formoterol
Number of subjects: 11729
Study 30537475 — intervention group
Group type: COMPARATOR
Intervention: Mometasone furoate
Number of subjects: 11729
Study 29102982 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated access to an interactive alcohol reduction website (FA)
Number of subjects: 763
Study 29102982 — intervention group
Group type: COMPARATOR
Intervention: Face‐to‐face brief intervention (BI)
Number of subjects: 763
Study 26449882 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OXT)
Number of subjects: 101
Study 26449882 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 26449882 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to favorite brand
Number of subjects: 101
Study 26449882 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline peripheral OXT concentrations
Number of subjects: 101
Study 24509938 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone gel applied to the wound after stitch-out for 1 month
Number of subjects: 100
Study 24509938 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 100
Study 22349543 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenotomy/Tenodesis (Group A)
Number of subjects: 65
Study 22349543 — intervention group
Group type: COMPARATOR
Intervention: Tenotomy (Group B)
Number of subjects: 65
Study 19476675 — intervention group
Group type: EXPERIMENTAL
Intervention: Free Fruit and Vegetable Snack (FFVS) + Enhanced Nutrition Education
Number of subjects: 1277
Study 19476675 — intervention group
Group type: EXPERIMENTAL
Intervention: FFVS-alone
Number of subjects: 1277
Study 19476675 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1277
Study 17096458 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 0
Study 17096458 — intervention group
Group type: COMPARATOR
Intervention: Antidepressant medication
Number of subjects: 0
Study 17096458 — intervention group
Group type: COMPARATOR
Intervention: Initial treatment assignment
Number of subjects: 0
Study 15358015 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular brachytherapy (VBT) with P-32 (20 Gy at 1 mm in the coronary wall) after direct stenting
Number of subjects: 112
Study 15358015 — intervention group
Group type: COMPARATOR
Intervention: No VBT (control group)
Number of subjects: 112
Study 11756905 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient care (early discharge)
Number of subjects: 95
Study 11756905 — intervention group
Group type: COMPARATOR
Intervention: Hospital care
Number of subjects: 95
Study 9659862 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided self-change (self-care manual plus eight fortnightly sessions of cognitive behavior therapy)
Number of subjects: 62
Study 9659862 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavior therapy (16 sessions of weekly cognitive behavior therapy)
Number of subjects: 62
Study 8925521 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood transfusion
Number of subjects: 0
Study 8925521 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor infiltrating lymphocytes (TIL)
Number of subjects: 0
Study 8925521 — intervention group
Group type: COMPARATOR
Intervention: Peripheral blood mononuclear cells (PBMC)
Number of subjects: 0
Study 2540724 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 0
Study 2540724 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of lithium carbonate and imipramine hydrochloride
Number of subjects: 0
Study 2540724 — intervention group
Group type: COMPARATOR
Intervention: Imipramine hydrochloride
Number of subjects: 0
Study 19510 — intervention group
Group type: EXPERIMENTAL
Intervention: Butaclamol (up to 50 mg/day)
Number of subjects: 0
Study 19510 — intervention group
Group type: EXPERIMENTAL
Intervention: Butaclamol (maintenance dose of 5 to 20 mg/day)
Number of subjects: 0
Study 19510 — intervention group
Group type: COMPARATOR
Intervention: Chlorpromazine (CPZ)
Number of subjects: 0
Study 31641058 — intervention group
Group type: EXPERIMENTAL
Intervention: CR messages with addiction warning
Number of subjects: 1528
Study 31641058 — intervention group
Group type: EXPERIMENTAL
Intervention: CR messages without addiction warning
Number of subjects: 1528
Study 31641058 — intervention group
Group type: EXPERIMENTAL
Intervention: NFS followed by CR messages with addiction warning
Number of subjects: 1528
Study 31641058 — intervention group
Group type: COMPARATOR
Intervention: Control messages
Number of subjects: 1528
Study 31641058 — intervention group
Group type: EXPERIMENTAL
Intervention: NFS condition
Number of subjects: 1528
Study 31429792 — intervention group
Group type: EXPERIMENTAL
Intervention: Covered stents (Advanta V12 over-the-wire, Atrium Maquet Getinge Group)
Number of subjects: 84
Study 31429792 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents (Palmaz Blue with rapid-exchange delivery system, Cordis Corporation)
Number of subjects: 84
Study 31429792 — intervention group
Group type: EXPERIMENTAL
Intervention: Covered stents
Number of subjects: 84
Study 31429792 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 84
Study 29157591 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring (TM)
Number of subjects: 0
Study 29157591 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study 24824772 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Cycling (MICC)
Number of subjects: 12
Study 24824772 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Intermittent Cycling (HIIC)
Number of subjects: 12
Study 24824772 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-Duration High-Intensity Intermittent Cycling (S-HIIC)
Number of subjects: 12
Study 24824772 — intervention group
Group type: COMPARATOR
Intervention: Resting Control
Number of subjects: 12
Study 24824772 — intervention group
Group type: EXPERIMENTAL
Intervention: All exercise bouts (MICC, HIIC, S-HIIC)
Number of subjects: 12
Study 25001274 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan 20 mg
Number of subjects: 133
Study 25001274 — intervention group
Group type: EXPERIMENTAL
Intervention: Olmesartan 40 mg and 80 mg
Number of subjects: 133